Table 2.

Follow-up time and anti-HBs levels during HIP treatment

Patient	Follow-up with HIP (years)	HIP transfusions (n)	HIP transfusions per year (mean)	HIP costs per year (USD)	Anti-HBs determinations (n)	Anti-HBs (IU/L) median (range)		Anti-HBs <200 IU/L n (%)		Anti-HBs <100 IU/L n (%)
H1	12.6	137	10.8	1512	134	259	(38-8578)	46	(34.3)	11	(8.2)
H2	10.5	86	8.2	1148	86	351	(84-17567)	21	(24.4)	3	(3.5)
H3	5.2	34	6.5	910	51	324	(108-3555)	9	(17.6)	0	(0)
H4	9.4	65	6.9	966	82	393	(116-2130)	10	(12.2)	0	(0)
H5	11.1	125	11.2	1568	133	711	(191-3911)	1	(0.8)	0	(0)
H6	5.0	35	7.0	980	37	518	(166-1798)	3	(8.1)	0	(0)
H7	8.7	69	7.9	1106	71	454	(107-1123)	8	(11.3)	0	(0)
H8	0.5	4	8.3	1162	7	188	(76-578)	4	(57.1)	1	(14.3)
H9	1.3	10	7.8	1092	12	508	(69-1050)	1	(8.3)	1	(8.3)
H10	0.9	8	9.4	1316	21	623	(273-3016)	0	(0)	0	(0)
H11	7.2	42	5.8	812	49	560	(217-1275)	0	(0)	0	(0)
H12	2.8	21	7.5	1050	39	512	(166-2976)	3	(7.7)	0	(0)
H13	6.1	41	6.7	938	50	884.5	(101-3266)	1	(2)	0	(0)
H14	2.1	15	7.2	1008	28	829.5	(191-5048)	2	(7.1)	0	(0)
H15	1.4	10	7.2	1008	21	609	(225-2728)	0	(0)	0	(0)
H16	0.5	4	7.8	1092	7	1939	(156-5558)	1	(14.3)	0	(0)
H17	4.9	33	6.8	952	26	445.5	(95-3792)	7	(26.9)	1	(3.8)
H18	1.1	10	9.5	1330	21	597	(14-2489)	3	(14.3)	2	(9.5)
H19	2.3	16	7.1	994	30	512.5	(49-4525)	2	(6.7)	1	(3.3)
H20	0.6	7	10.8	1512	12	775.5	(63-1000)	2	(16.7)	1	(8.3)
H21	0.9	10	11.4	1596	16	721.5	(208-1000)	0	(0)	0	(0)
All patients	95.1	782	8.2	1148	933	507	(14-17567)	124	(13.2)	21	(2.3)